Olympiad Research LP purchased a new stake in shares of Teladoc Health, Inc. (NYSE:TDOC – Free Report) during the 4th quarter, HoldingsChannel.com reports. The institutional investor purchased 20,457 shares of the health services provider’s stock, valued at approximately $186,000.
Several other institutional investors and hedge funds have also made changes to their positions in the company. Handelsbanken Fonder AB raised its position in shares of Teladoc Health by 27.1% during the 4th quarter. Handelsbanken Fonder AB now owns 36,600 shares of the health services provider’s stock valued at $333,000 after acquiring an additional 7,800 shares in the last quarter. Ieq Capital LLC acquired a new stake in Teladoc Health in the fourth quarter worth $111,000. C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors acquired a new stake in Teladoc Health in the fourth quarter worth $272,000. Rhumbline Advisers increased its position in Teladoc Health by 1.8% in the fourth quarter. Rhumbline Advisers now owns 281,420 shares of the health services provider’s stock worth $2,558,000 after buying an additional 5,018 shares during the period. Finally, Allspring Global Investments Holdings LLC acquired a new stake in Teladoc Health in the fourth quarter worth $2,859,000. 76.82% of the stock is owned by institutional investors and hedge funds.
Teladoc Health Trading Down 9.3 %
Shares of TDOC stock opened at $11.52 on Monday. The stock has a 50-day simple moving average of $10.55 and a 200 day simple moving average of $9.47. Teladoc Health, Inc. has a fifty-two week low of $6.76 and a fifty-two week high of $15.95. The stock has a market capitalization of $1.98 billion, a P/E ratio of -2.00 and a beta of 1.05. The company has a quick ratio of 1.69, a current ratio of 1.73 and a debt-to-equity ratio of 0.66.
Insider Activity at Teladoc Health
Analyst Ratings Changes
TDOC has been the topic of several analyst reports. Piper Sandler reaffirmed an “overweight” rating and issued a $13.00 target price (up from $11.00) on shares of Teladoc Health in a research report on Wednesday, December 4th. TD Cowen dropped their target price on Teladoc Health from $9.00 to $8.00 and set a “hold” rating on the stock in a research report on Thursday, October 31st. The Goldman Sachs Group increased their target price on Teladoc Health from $14.00 to $16.00 and gave the stock a “buy” rating in a research report on Tuesday, February 18th. Oppenheimer lowered their price target on Teladoc Health from $14.00 to $12.00 and set an “outperform” rating on the stock in a report on Friday, January 24th. Finally, Deutsche Bank Aktiengesellschaft raised their price target on Teladoc Health from $10.00 to $12.00 and gave the company a “hold” rating in a report on Friday, November 1st. Thirteen equities research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. According to data from MarketBeat, Teladoc Health currently has a consensus rating of “Hold” and a consensus price target of $11.81.
Get Our Latest Analysis on Teladoc Health
Teladoc Health Company Profile
Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.
Recommended Stories
- Five stocks we like better than Teladoc Health
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- Why Genuine Parts Company Is a Royally Good Buy Right Now
- 3 REITs to Buy and Hold for the Long Term
- Industrials Are Quietly Outpacing the Market: 3 Stocks to Watch
- The How and Why of Investing in Gold Stocks
- These 5 Energy Stocks Hedge Inflation With Growth Potential
Want to see what other hedge funds are holding TDOC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teladoc Health, Inc. (NYSE:TDOC – Free Report).
Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter.